| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 30, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 30, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE:COV) (the “Company”) confirms that, as of the close of business...
-
Jun 24, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 24, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
-
Jun 24, 2014Minimally-invasive flow diversion device for unruptured brain aneurysms designed for more accurate, controlled placement1
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European...
-
Jun 20, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
-
Jun 20, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
-
Jun 16, 2014Commitment Remains to Return 50 Percent of Free Cash Flow to Shareholders
MINNEAPOLIS - June 16, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT) approved yesterday a 9 percent increase in its cash dividend, raising the quarterly amount to $0.305 per share...
-
Jun 15, 2014Creates a Medical Technology and Services Company with a Comprehensive Product Portfolio and Broad Global Reach that is Better Able to Improve Healthcare Outcomes
MINNEAPOLIS AND DUBLIN - June 15, 2014 - Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology...
-
Jun 14, 2014Initial Focus on Insulin-Device Combinations and Care Management Services
PARIS, FRANCE, AND MINNEAPOLIS, MN - June 14, 2014 - Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to...
-
Jun 11, 2014Shareholders Invited to Attend Annual Meeting on Aug. 21, 2014
MINNEAPOLIS - June 11, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT), announced that the company's annual meeting of shareholders will be held at 10:30 a.m. CDT on Thursday, Aug....
-
Jun 11, 2014Global Leader Projects Introduction of IN.PACT Admiral Drug-coated Balloon to U.S. Market in Early FY16
MINNEAPOLIS - Date - Moving toward U.S. market introduction of its novel medical device to treat peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that it recently submitted...
-
Jun 10, 2014Apollo™ Onyx™ Delivery Micro Catheter with Detachable Tip Enhances Onyx™ Liquid Embolic System (LES) Delivery
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 10, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro catheter - the...
-
Jun 6, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jun 4, 2014Recently FDA Approved Valiant Captivia Proximal FreeFlo Tapers for Dissection and TOTAL Across Crossing Support Catheter Featured at the 2014 Vascular Annual Meeting
MINNEAPOLIS -- Jun. 4, 2014 -- Continuing to expand its market-leading portfolio of endovascular solutions, Medtronic, Inc. (NYSE: MDT) announced today that two recently Food and Drug...
-
Jun 4, 2014
HeartWare International, Inc. (Nasdaq: HTWR) announced that on June 3, 2014 it received a warning letter from the U.S. Food and Drug Administration (FDA) resulting from an inspection of the...
-
Jun 3, 2014
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jun 3, 2014
MINNEAPOLIS - June 3, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 35th annual Goldman Sachs Global Healthcare...
-
May 20, 2014TAVI and Surgical Patent Cases Resolved
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation (NYSE:EW). Under the terms of the...
-
May 20, 2014Q4 Revenue of $4.6 Billion Grew 3% at Constant Currency; 2% as Reported
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2014, which ended April 25, 2014. The company reported worldwide...
-
May 10, 2014Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...
-
May 10, 2014MINERVA Trial Presented at Heart Rhythm Meeting Shows Medtronic Advanced Pacing Features Reduce the Progression of Persistent AF by 58 Percent While Reducing AF-Related Hospital Visits That Lead to Increased Healthcare Costs
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing...
-
May 9, 2014Late-Breaking Clinical Trial Data Show Implant Success with Pacing Inside the Left Ventricle in Heart Failure Patients
MINNEAPOLIS and SAN FRANCISCO - May 9, 2014 - Medtronic, Inc. (NYSE: MDT) today released study findings that show heart failure patients who have limited options for implanted device therapy may...
-
May 7, 2014
ISTANBUL--(BUSINESS WIRE)--May 7, 2014-- Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation
-
May 1, 2014Final Follow-up of CoreValve CE Pivotal Study Shows Sustained Valve Function
MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...
-
May 1, 2014- Record 665 HeartWare® Ventricular Assist Systems sold worldwide in Q1; exceeds previous quarterly high of 549 units
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
May 1, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--May 1, 2014-- Covidien plc (NYSE: COV) will present at the Deutsche Bank 39th Annual Health Care Conference in Boston on May 8. Charles J. Dockendorff, executive...